Asit Parikh, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 10,000 shares at $4.42 ($44K) on 2025-03-13, disclosed to the SEC on 2025-03-17.
Open-market purchase of $44k PHAT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| PHAT | BUY | 2023-11-08 | $59K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $8K | — | Filing → |
| PHAT | BUY | 2023-02-14 | $39K | — | Filing → |